Apollo Endosurgery, Inc. (APEN) insider have most recently took part in a trading activity. On Jan 3, 2018 Stonepine Capital, L.p., 10% Owner bought 22,845 shares having total worth of $130,445 at the price of $5.71 per share, following the transaction a total of 2,577,996 shares owned by Stonepine Capital, L.p.. Before this latest buy, Stonepine Capital, L.p. purchased APEN at 2 other times during the past twelve months, for a total investment of $924,446 at an average of $4.93 per share.
The stock has experienced a total of 3 insider trades in the past three months. These trades include 3 buy trades. Furthermore, over the past 12 months , the stock was traded 17 times by insiders. In 2 of these trades, the insider was a seller while an employee of the company was the buyer in 15 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of Apollo Endosurgery, Inc. (APEN) traded up 5.18% on Jan 2, 2018, hitting $5.89. 85,711 shares of the company’s stock traded hands. Apollo Endosurgery, Inc. has a 52 week low of $3.77 and a 52 week high of $21.4. The company’s market cap is $0 million.
Apollo Endosurgery, Inc. (APEN) last announced its earnings results on Oct 26, 2017. The company reported 0.00 earnings per share (EPS) for the quarter, higher than the consensus estimate of -0.40 by $0.4., compared to the consensus estimate of $17 million. During the same quarter in the previous year, the company posted -1.54 earnings per share. The company’s revenue for the quarter was down 100% on a year-over-year basis.
|earnings per share||0.00||-0.64||-0.77|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018